Effect [qlco]    
Different [qlco]    
Schedule [inpr]    
Recurrence free survival [fndg]    
Liver Transplant [topp]    
Hepatocellular carcinoma [neop]    
Background [cnce]    
recurrence tumor [neop]    
Represent [acty]    
Main [qlco]    
limit [ftcn]    
Liver Transplant [topp]    
patient [podg]    
Hepatocellular carcinoma [neop]    
Exposure NOS [inpo]    
Calcineurin inhibitor [moft]    
Method [inpr]    
investigate [ftcn]    
Effect [qlco]    
Schedule [inpr]    
Exposure NOS [inpo]    
Calcineurin inhibitor [moft]    
patient [podg]    
Transplant [topp]    
Hepatocellular carcinoma [neop]    
recurrence tumor [neop]    
Rate [acty]    
Purpose [ftcn]    
Conduct [inbe]    
match [resa]    
Cohort Studies [qnco]    
31 [inpr]    
patient [podg]    
Hepatocellular carcinoma [neop]    
Transplant [topp]    
Receive [qlco]    
Part [spco]    
Immunosuppression [topp]    
a group [clas]    
Compare [acty]    
Control Group [grup]    
31 [inpr]    
patient [podg]    
Group [idcn]    
Transplant [topp]    
Same [qlco]    
period [tmco]    
Same [qlco]    
Prognostic Factor [clna]    
GIVEN [cnce]    
Standard [qlco]    
Immunosuppression [topp]    
base [ftcn]    
Result [ftcn]    
Three [qnco]    
year [tmco]    
Recurrence free survival [fndg]    
a group [clas]    
Group [idcn]    
Prevalence [qnco]    
Microvascular [ftcn]    
Invasion [fndg]    
Grade [clas]    
ng/mL [qnco]    
Identical [qlco]    
Two [qnco]    
Group [idcn]    
Exposure NOS [inpo]    
High [qlco]    
patient [podg]    
Group [idcn]    
median [spco]    
Ranges [qnco]    
5/5 [qnco]    
Comparison [acty]    
a group [clas]    
median [spco]    
Ranges [qnco]    
1+ [qnco]    
Conclusion [idcn]    
Using [ftcn]    
Exposure NOS [inpo]    
Calcineurin inhibitor [moft]    
Reduced [qlco]    
Risk [qlco]    
Hepatocellular carcinoma [neop]    
Recurrence [phpr]    
